MAPT and dementia: A potential approach to developing Tau-directed therapies against dementia could involve targeting the beginning of the Tau fibrilization cascade, thereby preventing the formation of toxic oligomeric species which are hypothesized to propagate from cell to cell in a prion-like manner [22, 34].